New drug trial targets debilitating dizziness in Parkinson's patients
Symptom relief
Recruiting now
This study is testing an experimental oral medication called CST-3056 to see if it can reduce symptoms like dizziness and lightheadedness in people with neurogenic orthostatic hypotension (nOH), a condition that causes a severe drop in blood pressure upon standing. The trial will…
Phase: PHASE2 • Sponsor: CuraSen Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC